Imaging of gliomas with Cis-4-[18F]fluoro-L-proline

被引:22
作者
Langen, KJ [1 ]
Jarosch, M
Hamacher, K
Mühlensiepen, H
Weber, F
Floeth, F
Pauleit, D
Herzog, H
Coenen, HH
机构
[1] Forschungszentrum Julich, Res Ctr, Inst Med, D-5170 Julich, Germany
[2] Forschungszentrum Julich, Res Ctr, Inst Nucl Chem, D-5170 Julich, Germany
[3] Univ Dusseldorf, Clin Nucl Med, D-4000 Dusseldorf, Germany
[4] Univ Dusseldorf, Clin Neurosurg, D-4000 Dusseldorf, Germany
关键词
cis-4-[F-18]fluoro-L-proline; amino acid transport; F98; glioma; autoradiography; PET;
D O I
10.1016/S0969-8051(03)00121-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Tumor imaging with cis-4-[F-18]fluoro-L-proline (cis-FPro) was compared to that of L-[H-3]proline and L-[H-3]methionine in F98 rat gliomas by dual-tracer autoradiography. All tracers exhibited high accumulation in the tumors but in the normal brain significant uptake was observed for L-[H-3]methionine only. Tumor extent on autoradiograms with L-[H-3]proline and L-[H-3]methionine was identical to that of histological staining while autoradiograms of cis-FPro showed diffuse uptake in the penumbra of some tumors. First PET studies in 7 patients with cerebral gliomas demonstrated accumulation of cis-FPro in tumor areas with enhancement of Gd-DTPA on MR scans. Uptake of cis-FPro in normal brain tissue was negligible. In one patient with a glioblastoma accumulation of cis-FPro was also found in two brain areas without enhancement of Gd-DTPA on MR scans. Control of MRI suggested tumor growth in these areas at further follow up. Our results indicate that in most gliomas increased cis-FPro uptake is restricted to areas with disruption of the BBB which limits its clinical utility. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 23 条
  • [2] Whole-body kinetics and dosimetry of cis-4-[18F]fluoro-L-proline
    Börner, AR
    Langen, KJ
    Herzog, H
    Hamacher, K
    Müller-Mattheis, V
    Schmitz, T
    Ackermann, R
    Coenen, HH
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (03) : 287 - 292
  • [3] Hamacher K, 1999, J LABELLED COMPD RAD, V42, P1135
  • [4] Target volumes in radiotherapy for high-grade malignant glioma of the brain
    Jansen, EPM
    Dewit, LGH
    van Herk, M
    Bartelink, H
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 56 (02) : 151 - 156
  • [5] Jones HA, 2003, J NUCL MED, V44, P483
  • [6] MORPHOLOGICAL CHARACTERIZATION OF NITROSOUREA-INDUCED GLIOMA CELL-LINES AND CLONES
    KO, L
    KOESTNER, A
    WECHSLER, W
    [J]. ACTA NEUROPATHOLOGICA, 1980, 51 (01) : 23 - 31
  • [7] Langen KJ, 1997, J NUCL MED, V38, P517
  • [8] Transport of cis- and trans-4-[18F]fluoro-L-proline in F98 glioma cells
    Langen, KJ
    Mühlensiepen, H
    Schmieder, S
    Hamacher, K
    Bröer, S
    Börner, AR
    Schneeweiss, FHA
    Coenen, HH
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (06) : 685 - 692
  • [9] Langen KJ, 2001, J NUCL MED, V42, P752
  • [10] Langen KJ, 1999, FRONT RADIAT THER ON, V33, P9